Enzolytics Inc (ENZC)

[suny66]

ENZC will enter a major board like NASDAQ through the "back door" by means of the recent reverse merge. By going this route they have some advantages~
1. Bioclonetics avoids having to seek private investors to raise required funds of at least $100M to get to the big board.
2. Reverse mergers custumarily take less time to make it to the big board.3. No Initial Public Offering(IPO) is needed.